See our work profiled in the new Asimov Press pandemic prevention mini-issue! Learn why we think antivirals are needed for "Day Zero" of the next pandemic – and get a glimpse into the research that we + others are carrying out to try and make that possible.
It took 326 days to get emergency use approval for the first mRNA vaccines. That's too slow. Omicron infected >1 billion people in China in 30 days. We need a way to slow the spread of pathogens before vaccines are available. Our essay today is about Panoplia Laboratories, a non-profit building broad-spectrum antivirals using tools from synthetic biology. Their goal is to make antivirals that can stop infections before they occur, and that are given before the onset of symptoms. Learn more about their work & subscribe: https://lnkd.in/gsWZKFda